- Home
- OSS vs VTAK Comparison
OSS vs VTAK Comparison
Compare OSS & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSS
- VTAK
- Stock Information
- Founded
- OSS 1998
- VTAK 2002
- Country
- OSS United States
- VTAK United States
- Employees
- OSS N/A
- VTAK N/A
- Industry
- OSS Computer Manufacturing
- VTAK Medical/Dental Instruments
- Sector
- OSS Technology
- VTAK Health Care
- Exchange
- OSS Nasdaq
- VTAK Nasdaq
- Market Cap
- OSS N/A
- VTAK 1.1M
- IPO Year
- OSS 2018
- VTAK 2018
- Fundamental
- Price
- OSS $2.41
- VTAK $0.38
- Analyst Decision
- OSS Strong Buy
- VTAK
- Analyst Count
- OSS 2
- VTAK 0
- Target Price
- OSS $5.25
- VTAK N/A
- AVG Volume (30 Days)
- OSS 66.7K
- VTAK 240.6K
- Earning Date
- OSS 11-07-2024
- VTAK 08-14-2024
- Dividend Yield
- OSS N/A
- VTAK N/A
- EPS Growth
- OSS N/A
- VTAK N/A
- EPS
- OSS N/A
- VTAK N/A
- Revenue
- OSS $52,756,487.00
- VTAK $436,000.00
- Revenue This Year
- OSS N/A
- VTAK $637.10
- Revenue Next Year
- OSS $10.29
- VTAK $177.13
- P/E Ratio
- OSS N/A
- VTAK N/A
- Revenue Growth
- OSS N/A
- VTAK 140.88
- 52 Week Low
- OSS $1.79
- VTAK $0.31
- 52 Week High
- OSS $4.58
- VTAK $4.10
- Technical
- Relative Strength Index (RSI)
- OSS 52.09
- VTAK 32.71
- Support Level
- OSS $2.22
- VTAK $0.35
- Resistance Level
- OSS $2.69
- VTAK $0.38
- Average True Range (ATR)
- OSS 0.22
- VTAK 0.04
- MACD
- OSS 0.01
- VTAK 0.05
- Stochastic Oscillator
- OSS 41.98
- VTAK 43.75
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.